| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | kainate selective glutamate receptor activity | 3.26e-05 | 6 | 30 | 2 | GO:0015277 | |
| GeneOntologyMolecularFunction | methylated histone binding | 2.88e-04 | 86 | 30 | 3 | GO:0035064 | |
| GeneOntologyMolecularFunction | glutamate-gated receptor activity | 2.93e-04 | 17 | 30 | 2 | GO:0004970 | |
| GeneOntologyMolecularFunction | methylation-dependent protein binding | 3.08e-04 | 88 | 30 | 3 | GO:0140034 | |
| GeneOntologyMolecularFunction | ligand-gated sodium channel activity | 3.29e-04 | 18 | 30 | 2 | GO:0015280 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 5.90e-04 | 24 | 30 | 2 | GO:0099507 | |
| GeneOntologyMolecularFunction | histone binding | 6.33e-04 | 265 | 30 | 4 | GO:0042393 | |
| GeneOntologyMolecularFunction | glutamate receptor activity | 7.48e-04 | 27 | 30 | 2 | GO:0008066 | |
| GeneOntologyMolecularFunction | potassium channel activity | 9.20e-04 | 128 | 30 | 3 | GO:0005267 | |
| GeneOntologyMolecularFunction | potassium ion transmembrane transporter activity | 1.98e-03 | 167 | 30 | 3 | GO:0015079 | |
| GeneOntologyMolecularFunction | sodium channel activity | 2.76e-03 | 52 | 30 | 2 | GO:0005272 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 3.31e-03 | 57 | 30 | 2 | GO:1904315 | |
| GeneOntologyMolecularFunction | modification-dependent protein binding | 3.58e-03 | 206 | 30 | 3 | GO:0140030 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential | 3.66e-03 | 60 | 30 | 2 | GO:0099529 | |
| GeneOntologyMolecularFunction | calcium-dependent phospholipid binding | 3.66e-03 | 60 | 30 | 2 | GO:0005544 | |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 4.28e-03 | 65 | 30 | 2 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 4.28e-03 | 65 | 30 | 2 | GO:0022824 | |
| GeneOntologyBiologicalProcess | monocyte activation involved in immune response | 2.05e-06 | 2 | 30 | 2 | GO:0002280 | |
| GeneOntologyBiologicalProcess | T-tubule organization | 7.32e-05 | 9 | 30 | 2 | GO:0033292 | |
| GeneOntologyBiologicalProcess | monocyte activation | 1.84e-04 | 14 | 30 | 2 | GO:0042117 | |
| GeneOntologyCellularComponent | kainate selective glutamate receptor complex | 2.98e-05 | 6 | 30 | 2 | GO:0032983 | |
| Domain | SPIN-2 | 2.49e-06 | 2 | 30 | 2 | IPR029564 | |
| Domain | FerA | 7.48e-06 | 3 | 30 | 2 | SM01200 | |
| Domain | Ferlin_A-domain | 7.48e-06 | 3 | 30 | 2 | IPR012560 | |
| Domain | FerA | 7.48e-06 | 3 | 30 | 2 | PF08165 | |
| Domain | DysFC | 1.49e-05 | 4 | 30 | 2 | SM00694 | |
| Domain | DysFN | 1.49e-05 | 4 | 30 | 2 | SM00693 | |
| Domain | Peroxin/Ferlin | 1.49e-05 | 4 | 30 | 2 | IPR006614 | |
| Domain | FerI | 2.49e-05 | 5 | 30 | 2 | SM01202 | |
| Domain | FerB | 2.49e-05 | 5 | 30 | 2 | SM01201 | |
| Domain | Ferlin_B-domain | 2.49e-05 | 5 | 30 | 2 | IPR012561 | |
| Domain | Ferlin_C | 2.49e-05 | 5 | 30 | 2 | PF16165 | |
| Domain | Ferlin_C | 2.49e-05 | 5 | 30 | 2 | IPR032362 | |
| Domain | FerIin_dom | 2.49e-05 | 5 | 30 | 2 | IPR012968 | |
| Domain | Spin-Ssty | 2.49e-05 | 5 | 30 | 2 | PF02513 | |
| Domain | SPIN/Ssty | 2.49e-05 | 5 | 30 | 2 | IPR003671 | |
| Domain | FerI | 2.49e-05 | 5 | 30 | 2 | PF08151 | |
| Domain | FerB | 2.49e-05 | 5 | 30 | 2 | PF08150 | |
| Domain | Iontro_rcpt | 3.76e-04 | 18 | 30 | 2 | IPR001320 | |
| Domain | Lig_chan | 3.76e-04 | 18 | 30 | 2 | PF00060 | |
| Domain | Lig_chan-Glu_bd | 3.76e-04 | 18 | 30 | 2 | PF10613 | |
| Domain | PBPe | 3.76e-04 | 18 | 30 | 2 | SM00079 | |
| Domain | Iono_rcpt_met | 3.76e-04 | 18 | 30 | 2 | IPR001508 | |
| Domain | Glu/Gly-bd | 3.76e-04 | 18 | 30 | 2 | IPR019594 | |
| Domain | Lig_chan-Glu_bd | 3.76e-04 | 18 | 30 | 2 | SM00918 | |
| Domain | Apc4_WD40_dom | 4.65e-04 | 20 | 30 | 2 | IPR024977 | |
| Domain | ANAPC4_WD40 | 4.65e-04 | 20 | 30 | 2 | PF12894 | |
| Domain | C2 | 1.19e-03 | 131 | 30 | 3 | PF00168 | |
| Domain | C2 | 1.36e-03 | 137 | 30 | 3 | SM00239 | |
| Domain | C2 | 1.50e-03 | 142 | 30 | 3 | PS50004 | |
| Domain | ANF_receptor | 1.60e-03 | 37 | 30 | 2 | PF01094 | |
| Domain | ANF_lig-bd_rcpt | 1.60e-03 | 37 | 30 | 2 | IPR001828 | |
| Domain | - | 1.69e-03 | 148 | 30 | 3 | 2.60.40.150 | |
| Domain | Peripla_BP_I | 1.78e-03 | 39 | 30 | 2 | IPR028082 | |
| Domain | CYSTEINE_SWITCH | 1.97e-03 | 41 | 30 | 2 | PS00546 | |
| Domain | Pept_M10_metallopeptidase | 2.16e-03 | 43 | 30 | 2 | IPR001818 | |
| Domain | C2_dom | 2.27e-03 | 164 | 30 | 3 | IPR000008 | |
| Domain | SANT | 2.91e-03 | 50 | 30 | 2 | SM00717 | |
| Domain | SANT/Myb | 3.15e-03 | 52 | 30 | 2 | IPR001005 | |
| Domain | MetalloPept_cat_dom | 7.47e-03 | 81 | 30 | 2 | IPR024079 | |
| Domain | - | 7.47e-03 | 81 | 30 | 2 | 3.40.390.10 | |
| Domain | WD40 | 8.12e-03 | 259 | 30 | 3 | PF00400 | |
| Domain | WD40 | 8.91e-03 | 268 | 30 | 3 | SM00320 | |
| Domain | WD40_repeat | 9.28e-03 | 272 | 30 | 3 | IPR001680 | |
| Domain | WD_REPEATS_1 | 9.84e-03 | 278 | 30 | 3 | PS00678 | |
| Domain | WD_REPEATS_2 | 9.94e-03 | 279 | 30 | 3 | PS50082 | |
| Domain | WD_REPEATS_REGION | 9.94e-03 | 279 | 30 | 3 | PS50294 | |
| Domain | ZINC_PROTEASE | 1.08e-02 | 98 | 30 | 2 | PS00142 | |
| Pathway | REACTOME_IONOTROPIC_ACTIVITY_OF_KAINATE_RECEPTORS | 6.12e-05 | 10 | 17 | 2 | M10272 | |
| Pathway | REACTOME_IONOTROPIC_ACTIVITY_OF_KAINATE_RECEPTORS | 8.97e-05 | 12 | 17 | 2 | MM15142 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 1.60e-04 | 90 | 17 | 3 | M631 | |
| Pathway | REACTOME_ACTIVATION_OF_KAINATE_RECEPTORS_UPON_GLUTAMATE_BINDING | 5.84e-04 | 30 | 17 | 2 | M18193 | |
| Pathway | REACTOME_ACTIVATION_OF_KAINATE_RECEPTORS_UPON_GLUTAMATE_BINDING | 6.65e-04 | 32 | 17 | 2 | MM15143 | |
| Pubmed | 6.15e-07 | 19 | 31 | 3 | 25367360 | ||
| Pubmed | 7.69e-07 | 2 | 31 | 2 | 22203159 | ||
| Pubmed | High-affinity kainate receptor subunits are necessary for ionotropic but not metabotropic signaling. | 7.69e-07 | 2 | 31 | 2 | 19778510 | |
| Pubmed | Accumulation of matrilysin (MMP-7) and macrophage metalloelastase (MMP-12) in actinic damage. | 7.69e-07 | 2 | 31 | 2 | 10504457 | |
| Pubmed | Subunit-specific desensitization of heteromeric kainate receptors. | 7.69e-07 | 2 | 31 | 2 | 20026616 | |
| Pubmed | Functional cloning of SPIN-2, a nuclear anti-apoptotic protein with roles in cell cycle progression. | 7.69e-07 | 2 | 31 | 2 | 12145692 | |
| Pubmed | 7.69e-07 | 2 | 31 | 2 | 9344615 | ||
| Pubmed | 2.31e-06 | 3 | 31 | 2 | 16325263 | ||
| Pubmed | The breast cancer beta 4 integrin and endothelial human CLCA2 mediate lung metastasis. | 2.31e-06 | 3 | 31 | 2 | 11320086 | |
| Pubmed | Distribution of kainate receptor subunits at hippocampal mossy fiber synapses. | 4.61e-06 | 4 | 31 | 2 | 12954862 | |
| Pubmed | Developmental expression patterns of kainate receptors in the mouse spinal cord. | 7.68e-06 | 5 | 31 | 2 | 23076118 | |
| Pubmed | 7.68e-06 | 5 | 31 | 2 | 26448475 | ||
| Pubmed | 7.68e-06 | 5 | 31 | 2 | 18358623 | ||
| Pubmed | 7.68e-06 | 5 | 31 | 2 | 8288598 | ||
| Pubmed | Kainate receptors: pharmacology, function and therapeutic potential. | 7.68e-06 | 5 | 31 | 2 | 18793656 | |
| Pubmed | Development of laminar distributions of kainate receptors in the somatosensory cortex of mice. | 7.68e-06 | 5 | 31 | 2 | 9593973 | |
| Pubmed | 7.68e-06 | 5 | 31 | 2 | 28228252 | ||
| Pubmed | 7.68e-06 | 5 | 31 | 2 | 12223554 | ||
| Pubmed | Preferential assembly of heteromeric kainate and AMPA receptor amino terminal domains. | 7.68e-06 | 5 | 31 | 2 | 29058671 | |
| Pubmed | N-glycan content modulates kainate receptor functional properties. | 1.15e-05 | 6 | 31 | 2 | 28714086 | |
| Pubmed | A transcriptional coregulator, SPIN·DOC, attenuates the coactivator activity of Spindlin1. | 1.15e-05 | 6 | 31 | 2 | 29061846 | |
| Pubmed | 1.61e-05 | 7 | 31 | 2 | 19342380 | ||
| Pubmed | 1.61e-05 | 7 | 31 | 2 | 17428973 | ||
| Pubmed | 2.15e-05 | 8 | 31 | 2 | 19125103 | ||
| Pubmed | Expression of glutamate receptor subunit genes during development of the mouse retina. | 2.76e-05 | 9 | 31 | 2 | 9051806 | |
| Pubmed | 2.76e-05 | 9 | 31 | 2 | 7527545 | ||
| Pubmed | 2.76e-05 | 9 | 31 | 2 | 34100982 | ||
| Pubmed | A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome. | 3.29e-05 | 420 | 31 | 5 | 28065597 | |
| Pubmed | Glutamate can act as a signaling molecule in mouse preimplantation embryos†. | 2.10e-04 | 24 | 31 | 2 | 35746896 | |
| Pubmed | ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. | 2.66e-04 | 27 | 31 | 2 | 17525332 | |
| Pubmed | 3.08e-04 | 29 | 31 | 2 | 19094228 | ||
| Pubmed | 4.49e-04 | 35 | 31 | 2 | 28106071 | ||
| Pubmed | CDK5RAP3, a UFL1 substrate adaptor, is crucial for liver development. | 4.75e-04 | 36 | 31 | 2 | 30635284 | |
| Cytoband | Xp11.1 | 2.82e-06 | 4 | 32 | 2 | Xp11.1 | |
| Cytoband | 17q25 | 3.43e-04 | 39 | 32 | 2 | 17q25 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrXp11 | 2.28e-03 | 377 | 32 | 3 | chrXp11 | |
| GeneFamily | Glutamate ionotropic receptor kainate type subunits | 1.54e-05 | 5 | 23 | 2 | 1199 | |
| GeneFamily | Tudor domain containing|Spindlin family | 1.54e-05 | 5 | 23 | 2 | 1089 | |
| GeneFamily | Ferlin family | 2.31e-05 | 6 | 23 | 2 | 828 | |
| GeneFamily | Tudor domain containing | 1.00e-03 | 37 | 23 | 2 | 780 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 2.05e-03 | 53 | 23 | 2 | 532 | |
| GeneFamily | WD repeat domain containing | 4.30e-03 | 262 | 23 | 3 | 362 | |
| Coexpression | GAL_LEUKEMIC_STEM_CELL_UP | 1.64e-05 | 130 | 31 | 4 | M17428 | |
| ToppCell | droplet-Lung-nan-3m-Lymphocytic-Regulatory_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.22e-06 | 168 | 32 | 4 | 1df3c8c7a6dceb901805eaba7f86f9943f4f1a9d | |
| ToppCell | droplet-Lung-nan-3m-Lymphocytic-regulatory_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.22e-06 | 168 | 32 | 4 | 1586451d437b70b2dffe41d782b694702dcaf50b | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuronal-Neuron|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 1.07e-04 | 129 | 32 | 3 | 64768adf23123b92280fb30eb85147cbee084ae0 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-04 | 135 | 32 | 3 | 8521107817df49efd9a2e81078c8535ed33e729c | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-Neutrophil-Neu_1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.43e-04 | 142 | 32 | 3 | 191a13bba143ecdfc2bfd797c3ac191481388298 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-Neutrophil-Neu_1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.46e-04 | 143 | 32 | 3 | b405dba9a83a99cc7b53ce71772bc52a0bbb0d4e | |
| ToppCell | Adult-Epithelial-basal_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.78e-04 | 153 | 32 | 3 | 9ee3e7f3f19a2474283c1c79045269686f35a541 | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-04 | 157 | 32 | 3 | a426c54fd1545093d41426e9620862f71bd06f6b | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.14e-04 | 163 | 32 | 3 | 8e32b6431e1862572663aa6ddc4ea299c6acc8a6 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.14e-04 | 163 | 32 | 3 | bbc078761c5043af13d9a6fcf3145a3e300bae5e | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-Tfh|bone_marrow / Manually curated celltypes from each tissue | 2.26e-04 | 166 | 32 | 3 | 9ac5267d3a53a96dec9eae3bc01acba4750742c8 | |
| ToppCell | NS-critical-d_0-4-Epithelial-Secretory|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.38e-04 | 169 | 32 | 3 | aec97583b23112060437b619cb429dc32f29285f | |
| ToppCell | AT1-AT2_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 2.51e-04 | 172 | 32 | 3 | 0be41df5d35d818deb7316ac21c9366eb4b7bfd1 | |
| ToppCell | PSB-critical-LOC-Myeloid-Basophil|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.78e-04 | 178 | 32 | 3 | 45bdbb96094c97756e1b6eebd80eadd8472143f2 | |
| ToppCell | AT1-AT2_cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 2.87e-04 | 180 | 32 | 3 | 3c7b2033821f9e34e2924bd8655f566edcbcc7d3 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.91e-04 | 181 | 32 | 3 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | nucseq-Immune-Lymphocytic_B-Lymphocytic_B-B|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.91e-04 | 181 | 32 | 3 | 8d8cc4dae2c8bd5f4b1c159f2a52edc4c9449c86 | |
| ToppCell | Control-Epithelial_cells-Airway_mucous|Control / group, cell type (main and fine annotations) | 3.01e-04 | 183 | 32 | 3 | 15d24a4fb1ffe6cbafbd54fcd7dde9ddcfbe03b2 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-classical_monocyte_proliferating|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.01e-04 | 183 | 32 | 3 | 6c1d7ce60e67bf1df364a4e177c351e7313eb41f | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Lymphocytic-T-T_CD8-CD8_TRM|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.06e-04 | 184 | 32 | 3 | 17ffa0e890960c00a3b5fa33d48caba66c61dbb0 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-classical_monocyte_proliferating-classical_monocyte_proliferating_l33-52|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.11e-04 | 185 | 32 | 3 | 47c69500877b851c0c9744f5e1ef2ee0bff99168 | |
| ToppCell | nucseq-Immune-Lymphocytic_B-Lymphocytic_B-Plasma|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.11e-04 | 185 | 32 | 3 | 3b77bc49cd3740acc025e162a36282ac09e12198 | |
| ToppCell | droplet-Heart-nan-18m-Neuronal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.11e-04 | 185 | 32 | 3 | c61267cfadea018794f7964904445787629a40d1 | |
| ToppCell | droplet-Heart-nan-18m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.11e-04 | 185 | 32 | 3 | 3a592719d5643011954f89d5bb61a5e94682b68e | |
| ToppCell | COVID-19_Convalescent-Lymphoid_B-B_naive|COVID-19_Convalescent / Disease group, lineage and cell class | 3.16e-04 | 186 | 32 | 3 | 9d339f57036d17572882ebb801f2be9b1d1ddc1c | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neuron_precursor-Neuroblast|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.21e-04 | 187 | 32 | 3 | dfc2b95d70daf533bc0cc4ce78af9f65dd75a25b | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 3.21e-04 | 187 | 32 | 3 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l32-30|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.26e-04 | 188 | 32 | 3 | 502045a39ffb1e92bd9499848368e8fa971edb88 | |
| ToppCell | droplet-Heart-HEART-1m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.31e-04 | 189 | 32 | 3 | 4e61f9cd1c06bddb47ebf98affc0f97770e26e8c | |
| ToppCell | COVID-19-lung-Secretory|lung / Disease (COVID-19 only), tissue and cell type | 3.31e-04 | 189 | 32 | 3 | 84d48e3ed25bebb8bb8074b3a2c5e2e88cff7f25 | |
| ToppCell | Severe_COVID-19-Epithelial-undefined_Epi|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 3.31e-04 | 189 | 32 | 3 | 8cbd35320c7e7ff013ef0c0f13f8d875db1c53cd | |
| ToppCell | droplet-Heart-HEART-1m-Neuronal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.31e-04 | 189 | 32 | 3 | a618a1ddf5097a010c6c2c7341f3a0bd46a29c02 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.31e-04 | 189 | 32 | 3 | 8130102c41b2978a8b83f765ce383f836a464795 | |
| ToppCell | IPF-Epithelial-Aberrant_Basaloid|World / Disease state, Lineage and Cell class | 3.31e-04 | 189 | 32 | 3 | 8030a353473da34ae92429f2d822171a2e94248f | |
| ToppCell | ICU-SEP-Lymphocyte-T_NK-CD4_TCM|ICU-SEP / Disease, Lineage and Cell Type | 3.31e-04 | 189 | 32 | 3 | 9ed1cf4bb456780c1d1070de687bcabafd6287a3 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.31e-04 | 189 | 32 | 3 | 7ccea2df93bb4b37417bbc8f6c85a61ece95211a | |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_B-GC_B_(II)|GI_large-bowel / Manually curated celltypes from each tissue | 3.36e-04 | 190 | 32 | 3 | fee64bacbb330d04dc1dc63909838f2c605d9f1f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.36e-04 | 190 | 32 | 3 | 1f83f7f24288a3b9ab33c2e113e845dba96adc8a | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-C_(Myofibroblast)|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.36e-04 | 190 | 32 | 3 | 71e112dfb8c3190fe0286b45a046ea789eb6a8db | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.36e-04 | 190 | 32 | 3 | 2306aa9dbeaef3be8484a5b236605de23cd75d4c | |
| ToppCell | Control-Myeloid-transitional_Macro|Control / Disease group,lineage and cell class (2021.01.30) | 3.41e-04 | 191 | 32 | 3 | 3ed0b1ff628a165e3c92c2e493206015f57dccfe | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-T_cells-Activated_CD4_T|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.41e-04 | 191 | 32 | 3 | dabb2d0210e39455db99db155cb36a3b6af43f37 | |
| ToppCell | (1)_T_CD4_fh|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 3.41e-04 | 191 | 32 | 3 | 66ddff9a99092cb384b9fb2a3ba95ddbebed67cc | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neuron_precursor|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.41e-04 | 191 | 32 | 3 | a53616c84178eb6c29b48662358765b082df3f97 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-NK|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.46e-04 | 192 | 32 | 3 | 930319cbd82b9e54864147ffcdc8bd0ea7b937be | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_naive-B_naive-13|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.46e-04 | 192 | 32 | 3 | e5ab932b4c2fed538161281ae07dfcdd82706fdd | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-NK-NK|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.46e-04 | 192 | 32 | 3 | c7bcebcb88a25b2c97d798120efa9d5958e7f798 | |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 3.46e-04 | 192 | 32 | 3 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| ToppCell | Control-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 3.52e-04 | 193 | 32 | 3 | 5896242f713ae5fd1a4ebb63827f15d7279dced2 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 3.52e-04 | 193 | 32 | 3 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.52e-04 | 193 | 32 | 3 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.52e-04 | 193 | 32 | 3 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.52e-04 | 193 | 32 | 3 | 194b49c152e3e3f599068ec88a7f0af6427b743a | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 3.52e-04 | 193 | 32 | 3 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.57e-04 | 194 | 32 | 3 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_naive-4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.57e-04 | 194 | 32 | 3 | 24f9de4781666c96c4a2d04f8a444543dbd99cbe | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.57e-04 | 194 | 32 | 3 | 81713e0409e8be695ba5dfdc67a997b33435dd9e | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.57e-04 | 194 | 32 | 3 | e93de9428c986b8943fc169258847c650cfab0e5 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.57e-04 | 194 | 32 | 3 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | BLOOD--(1)_T_cell-(1)_MAIT-like_CD8_T_cells|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.57e-04 | 194 | 32 | 3 | 830342a4df39c24c30fb4746ce762af697716148 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.57e-04 | 194 | 32 | 3 | 90efdbd7f1c85fd7fd622b10340250b1d8fc1197 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.57e-04 | 194 | 32 | 3 | df82cce5ebeb73740b02cf816c6df82253cfd566 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_naive|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.57e-04 | 194 | 32 | 3 | 82753b90ca3b563275c41b6040ebbcd99b185e24 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.57e-04 | 194 | 32 | 3 | 627cffe2d448e74fc5df92e74e5b922a73304137 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_naive|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.62e-04 | 195 | 32 | 3 | e830f0c545be87a1056a4505bdf6845e5ac7750d | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 3.62e-04 | 195 | 32 | 3 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | COVID-19_Severe-Lymphoid_B-B_naive|COVID-19_Severe / Disease group, lineage and cell class | 3.62e-04 | 195 | 32 | 3 | 71563e838fcda34a9a209c5433e0d84420373402 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_naive-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.62e-04 | 195 | 32 | 3 | 8f5a664dd65c38afe23c6acd0a9c22ba4fd347ed | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-transitional_Epi-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.68e-04 | 196 | 32 | 3 | 1efacc37bbfbd05b5d4db3dd10f6d9a238d23e31 | |
| ToppCell | IPF-Lymphoid-T|Lymphoid / Disease state, Lineage and Cell class | 3.68e-04 | 196 | 32 | 3 | 6e70c48a63d9673eb16b0847c1bd88eecc2f7a3c | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.68e-04 | 196 | 32 | 3 | b07db4a53ab9be9aad6fae5e45f9547db829d096 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Goblet|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.68e-04 | 196 | 32 | 3 | c366f980cc04abfe1c0c14746c11810c812a42c0 | |
| ToppCell | COPD-Lymphoid-T|Lymphoid / Disease state, Lineage and Cell class | 3.68e-04 | 196 | 32 | 3 | c9bdd505c3ab380ed7b272aa518df31a0a706a06 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-transitional_Epi|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.68e-04 | 196 | 32 | 3 | 3e99a367b7d817e1f1221450fcec20ad7a7c7a2a | |
| ToppCell | Severe_COVID-19-Epithelial-transitional_Epi|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 3.73e-04 | 197 | 32 | 3 | 5ad3cd4c77016e862041baac3076f8cc0f75c417 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-transitional_Epi-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.73e-04 | 197 | 32 | 3 | 08b371309cd790b171ed76cabc7d910e71cd2835 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.73e-04 | 197 | 32 | 3 | b349f8e96d61a4c296af64711e11fc44459a9413 | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-Basal_1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 3.73e-04 | 197 | 32 | 3 | 2701864e49878c5f323f5133e2c4b0a5a7fff7f5 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Basal_1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.73e-04 | 197 | 32 | 3 | 751f19b00f92e1334f653b870d3f7c0c149ff41a | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.73e-04 | 197 | 32 | 3 | 6d027119a5f7ca2aac1b10837e43f9a2bb54db85 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Basal_1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.73e-04 | 197 | 32 | 3 | 58d809ccb8cc4b1e76acf0b8f996cd0e2637290c | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4|Liver / Manually curated celltypes from each tissue | 3.73e-04 | 197 | 32 | 3 | 4891111894b741555f549deec6af8006376d9358 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-transitional_Epi|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.73e-04 | 197 | 32 | 3 | 9f49feee38647bbf964974aac96fa75602186b5c | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.73e-04 | 197 | 32 | 3 | c2e390653d5dee7e731c1840cfdab41987dede9b | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 3.73e-04 | 197 | 32 | 3 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | severe-Myeloid-Immature_Neutrophils_2|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.79e-04 | 198 | 32 | 3 | 844f534551483c89ef789d1cfeb4680e54f794b2 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4|bone_marrow / Manually curated celltypes from each tissue | 3.79e-04 | 198 | 32 | 3 | f2d85d7ca0e867d20ad4d2b1cbbfd91a066c1a03 | |
| ToppCell | severe-Myeloid-Immature_Neutrophils_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.79e-04 | 198 | 32 | 3 | e36303628af3139310c1d7a84d2919b7319bbda4 | |
| ToppCell | COVID-19-COVID-19_Mild-Myeloid-immature_Neutrophil|COVID-19_Mild / Disease, condition lineage and cell class | 3.85e-04 | 199 | 32 | 3 | e222b90caf45904d8f763574e7b6aac13333df92 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-AT1|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.85e-04 | 199 | 32 | 3 | 3e35ee426ef06f9af568c37349b62dd1ee9b97ea | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-AT1-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.85e-04 | 199 | 32 | 3 | f8846446ebbc4948cdc69640782db1358bbdc486 | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_airway_basal-Dividing_Basal|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.85e-04 | 199 | 32 | 3 | f0c289523957258d16135c04679db379d43d28d9 | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-AT1|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 3.85e-04 | 199 | 32 | 3 | fe9f5bc317be0c35bd96311bf0b3c7b91d98acc5 | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.90e-04 | 200 | 32 | 3 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-B-B_naive|COVID-19_Severe / Disease, condition lineage and cell class | 3.90e-04 | 200 | 32 | 3 | 5ba9c541fa356d34f392a63274dcd7bfb844cbb6 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW08|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 3.90e-04 | 200 | 32 | 3 | 9b614b8b949aa7d3ddbe613db6e08adaf04535a7 | |
| ToppCell | COVID-19-COVID-19_Convalescent-Lymphocyte-B-B_naive|COVID-19_Convalescent / Disease, condition lineage and cell class | 3.90e-04 | 200 | 32 | 3 | 5c1b51b9571681d8b792d1443d9f8926dcd55b29 | |
| ToppCell | Severe-Epithelial-Epithelial-|Severe / Condition, Lineage, Cell class and cell subclass | 3.90e-04 | 200 | 32 | 3 | 8669ce08f93eefb8ac970e30cdc4b1f908023c54 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Mesenchymal|10w / Sample Type, Dataset, Time_group, and Cell type. | 3.90e-04 | 200 | 32 | 3 | c968d077b7fd24fb06cedb51c737996f25667eb7 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.90e-04 | 200 | 32 | 3 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| Drug | 1,3-glyceryl dinitrate | 2.72e-07 | 10 | 31 | 3 | CID000012200 | |
| Drug | dinitroglycerol | 8.23e-07 | 14 | 31 | 3 | CID000079076 | |
| Drug | lithium indium | 1.79e-06 | 2 | 31 | 2 | CID011116062 | |
| Drug | rubidium nitrate | 1.79e-06 | 2 | 31 | 2 | CID000025731 | |
| Drug | scandium phosphate | 1.79e-06 | 2 | 31 | 2 | CID006365269 | |
| Drug | aminothiazole 6 | 1.07e-05 | 4 | 31 | 2 | CID005329388 | |
| Drug | acromelic acid B | 1.07e-05 | 4 | 31 | 2 | CID000158974 | |
| Drug | Brn 1074551 | 1.07e-05 | 4 | 31 | 2 | CID000120220 | |
| Drug | diphenylketen | 1.07e-05 | 4 | 31 | 2 | CID000013696 | |
| Drug | 4-methyleneglutamic acid | 1.07e-05 | 4 | 31 | 2 | CID000096407 | |
| Drug | diCl-HQC | 1.07e-05 | 4 | 31 | 2 | CID003018579 | |
| Drug | CPPG | 1.33e-05 | 34 | 31 | 3 | CID000002878 | |
| Drug | 3-hydroxy-2-quinoxalinecarboxylic acid | 1.79e-05 | 5 | 31 | 2 | CID000071001 | |
| Drug | bromowillardiine | 1.79e-05 | 5 | 31 | 2 | CID000167842 | |
| Drug | ipenoxazone | 1.79e-05 | 5 | 31 | 2 | CID000065882 | |
| Drug | pBB-PzDA | 1.79e-05 | 5 | 31 | 2 | CID000124528 | |
| Drug | ethyl propiolate | 1.79e-05 | 5 | 31 | 2 | CID000012182 | |
| Drug | pyrimidine-2,4-dione | 1.79e-05 | 5 | 31 | 2 | CID000150747 | |
| Drug | 3-acetylisoquinoline | 2.68e-05 | 6 | 31 | 2 | CID000124656 | |
| Drug | fluorocyclobutane | 3.75e-05 | 7 | 31 | 2 | CID011051569 | |
| Drug | alclofenac | 3.75e-05 | 7 | 31 | 2 | CID000030951 | |
| Drug | 1v79 | 5.00e-05 | 8 | 31 | 2 | CID000449014 | |
| Drug | norcyclizine | 5.00e-05 | 8 | 31 | 2 | CID000070048 | |
| Drug | AC1L1B65 | 5.00e-05 | 8 | 31 | 2 | CID000001300 | |
| Drug | perzinfotel | 5.00e-05 | 8 | 31 | 2 | CID006918236 | |
| Drug | Ly294486 | 6.42e-05 | 9 | 31 | 2 | CID005311255 | |
| Drug | propyl pyrazole triol | 6.42e-05 | 9 | 31 | 2 | CID006095481 | |
| Drug | oxalyl chloride | 6.42e-05 | 9 | 31 | 2 | CID000065578 | |
| Drug | benzo(F)quinoxaline | 6.42e-05 | 9 | 31 | 2 | CID000098494 | |
| Drug | NS3763 | 6.42e-05 | 9 | 31 | 2 | CID004359312 | |
| Drug | lithium 3,5-diiodosalicylate | 6.42e-05 | 9 | 31 | 2 | CID002735070 | |
| Drug | LY339434 | 6.42e-05 | 9 | 31 | 2 | CID006324635 | |
| Drug | AC1L1CXL | 8.02e-05 | 10 | 31 | 2 | CID000002106 | |
| Drug | sym 2206 | 9.79e-05 | 11 | 31 | 2 | CID005039877 | |
| Drug | Atpa | 1.17e-04 | 12 | 31 | 2 | CID000002252 | |
| Drug | Span® 80 | 1.17e-04 | 12 | 31 | 2 | CID000347521 | |
| Drug | (+) -Levobunolol hydrochloride [47141-41-3]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 1.37e-04 | 195 | 31 | 4 | 4980_DN | |
| Drug | AC1L1K9N | 1.39e-04 | 13 | 31 | 2 | CID000005398 | |
| Drug | Bambuterol hydrochloride [81732-46-9]; Down 200; 10uM; MCF7; HT_HG-U133A | 1.40e-04 | 196 | 31 | 4 | 3199_DN | |
| Drug | Pivampicillin [33817-20-8]; Up 200; 8.6uM; PC3; HT_HG-U133A | 1.42e-04 | 197 | 31 | 4 | 5046_UP | |
| Drug | AC1L1DME | 1.44e-04 | 75 | 31 | 3 | CID000002414 | |
| Drug | clozapine; Up 200; 10uM; HL60; HT_HG-U133A | 1.45e-04 | 198 | 31 | 4 | 1170_UP | |
| Drug | ACEA-1011 | 1.86e-04 | 15 | 31 | 2 | CID000127872 | |
| Drug | TG-1 | 1.86e-04 | 15 | 31 | 2 | CID000060499 | |
| Drug | QX-314 | 1.88e-04 | 82 | 31 | 3 | CID000003925 | |
| Drug | argiopine | 2.13e-04 | 16 | 31 | 2 | CID000122294 | |
| Drug | decahydroisoquinoline | 2.13e-04 | 16 | 31 | 2 | CID000097812 | |
| Drug | K-11 | 2.41e-04 | 17 | 31 | 2 | CID000469667 | |
| Drug | 3HPG | 2.41e-04 | 17 | 31 | 2 | CID000001217 | |
| Drug | acromelic acid A | 2.71e-04 | 18 | 31 | 2 | CID000108086 | |
| Drug | LY382884 | 3.02e-04 | 19 | 31 | 2 | CID000656723 | |
| Drug | IDRA 21 | 3.36e-04 | 20 | 31 | 2 | CID000003688 | |
| Drug | AC1N8N2J | 3.36e-04 | 20 | 31 | 2 | CID004346372 | |
| Drug | Azone | 3.36e-04 | 20 | 31 | 2 | CID000042981 | |
| Drug | 4-carboxy-3-hydroxyphenylglycine | 3.36e-04 | 20 | 31 | 2 | CID000001297 | |
| Drug | AC1LAED8 | 3.71e-04 | 21 | 31 | 2 | CID000486506 | |
| Drug | tren | 3.71e-04 | 21 | 31 | 2 | CID000077731 | |
| Drug | chlorcyclizine | 3.71e-04 | 21 | 31 | 2 | CID000002710 | |
| Drug | CX546 | 3.71e-04 | 21 | 31 | 2 | CID000002890 | |
| Drug | AC1L1B62 | 3.71e-04 | 21 | 31 | 2 | CID000001299 | |
| Drug | NS 102 | 4.07e-04 | 22 | 31 | 2 | CID005282252 | |
| Drug | CX516 | 4.07e-04 | 22 | 31 | 2 | CID000148184 | |
| Drug | YM90K | 4.46e-04 | 23 | 31 | 2 | CID005486547 | |
| Drug | CGP 39653 | 4.86e-04 | 24 | 31 | 2 | CID006437837 | |
| Drug | gavestinel | 5.28e-04 | 25 | 31 | 2 | CID006450546 | |
| Drug | Ns102 | 5.28e-04 | 25 | 31 | 2 | CID005311098 | |
| Drug | VX-497 | 6.17e-04 | 27 | 31 | 2 | CID000153241 | |
| Drug | L-689,560 | 6.17e-04 | 27 | 31 | 2 | CID000121918 | |
| Disease | Astigmatism | 1.14e-05 | 129 | 32 | 4 | HP_0000483 | |
| Disease | limb-girdle muscular dystrophy (implicated_via_orthology) | 2.38e-05 | 7 | 32 | 2 | DOID:11724 (implicated_via_orthology) | |
| Disease | gastric adenocarcinoma (is_implicated_in) | 6.23e-05 | 11 | 32 | 2 | DOID:3717 (is_implicated_in) | |
| Disease | Abortion, Tubal | 2.25e-04 | 109 | 32 | 3 | C0000822 | |
| Disease | Early Pregnancy Loss | 2.25e-04 | 109 | 32 | 3 | C3830362 | |
| Disease | Miscarriage | 2.25e-04 | 109 | 32 | 3 | C4552766 | |
| Disease | Spontaneous abortion | 2.25e-04 | 109 | 32 | 3 | C0000786 | |
| Disease | APOE carrier status, cerebral amyloid angiopathy | 9.55e-04 | 42 | 32 | 2 | EFO_0006790, EFO_0007659 | |
| Disease | prostate specific antigen measurement | 1.10e-03 | 188 | 32 | 3 | EFO_0004624 | |
| Disease | Alzheimer disease, dementia, family history of Alzheimer’s disease | 1.25e-03 | 48 | 32 | 2 | EFO_0009268, MONDO_0001627, MONDO_0004975 | |
| Disease | Schizophrenia | 2.44e-03 | 883 | 32 | 5 | C0036341 | |
| Disease | congenital heart disease (implicated_via_orthology) | 2.55e-03 | 69 | 32 | 2 | DOID:1682 (implicated_via_orthology) | |
| Disease | late-onset Alzheimers disease | 3.85e-03 | 292 | 32 | 3 | EFO_1001870 | |
| Disease | calcium measurement | 4.55e-03 | 628 | 32 | 4 | EFO_0004838 | |
| Disease | economic and social preference | 4.97e-03 | 97 | 32 | 2 | EFO_0004827 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EWCRGRPHGKGTLKW | 361 | Q60I27 | |
| LEQHVPESEGWWKCL | 41 | Q9NQ75 | |
| PESEGWWKCLLHGRQ | 46 | Q9NQ75 | |
| EAEKWGHVGGCHPKW | 321 | Q86UQ4 | |
| WLGPKAWHECEMLEL | 3981 | Q96M86 | |
| KPQWHDLLPCKLGIW | 216 | Q96KC8 | |
| WKGPRGCWKAVVAEK | 326 | Q7L9B9 | |
| HLRPCAGWKVGNWSK | 1361 | P58397 | |
| HWVGLKKEPGHPWKW | 141 | Q07108 | |
| WGKEIPLHFRKVVWG | 136 | P09237 | |
| DKKPLEAGVWCWDRG | 126 | Q4VX62 | |
| WCGHCKQLAPIWDKL | 396 | P07237 | |
| HKKKDCPPGSFWWLI | 701 | P16144 | |
| LPVWWECGKHDRDLL | 1571 | Q8TD26 | |
| KHVSPLWELIKWCLG | 386 | Q6GMR7 | |
| EIKGIPWASWTCVKG | 491 | Q6ZMW3 | |
| RKWWEGGKCPKEEDH | 781 | Q16099 | |
| KWWEGGRCPKEEDHR | 781 | Q16478 | |
| KGWWPCVAEEGEKKI | 1966 | O75923 | |
| PLCEVDLVKGGHWWK | 296 | Q9BSW7 | |
| DLVKGGHWWKALIPS | 301 | Q9BSW7 | |
| VKCPQGWHFKKDWVV | 891 | A0AVI2 | |
| HGWKEGDEPITQWKG | 56 | Q99865 | |
| WSLEQPEWHCKIDEG | 76 | Q9P2S5 | |
| IWLKAGLKEAPEGWQ | 176 | Q9NWT8 | |
| DLCVTWWEKGLPAKE | 146 | Q86XI2 | |
| QVILEKGWCGWKGPD | 436 | Q9NUQ7 | |
| HGWKEGDEPITQWKG | 56 | Q9BPZ2 | |
| TIWDVGGKHKLRPLW | 451 | P36406 | |
| AGIPHEHRSKVWKWC | 661 | Q9UPU7 | |
| KGHEGSVACLWWDPI | 196 | Q8IWB7 | |
| VEDSILGPWGKWRCL | 51 | A0A1W2PP97 | |
| LLTVPKGGWKCKWCV | 1461 | O14686 | |
| SLLKWEVGWLHELGK | 386 | Q96L42 |